Table 2.
Participant Characteristics
| Characteristic | Proportion n (%) |
|---|---|
| Days of Observation Mean [Range] | 25.34 [9-30] |
| Days Between T1 and T2 (M, SD) | 36.1 (12.6) |
| Days Between T2 and T3 (M, SD) | 29.8 (11.2) |
| Average Days in Study | 92.3 (20.7) |
| Age Mean [Range] | 48.6 [31-71] |
| BMI Mean [Range] | 27.6 [17.9-52.5] |
| Race | |
| White | 51 (76.6) |
| African American | 8 (10.9) |
| Asian/Pacific Islander | 4 (6.3) |
| Other | 4 (6.3) |
| Hispanic or Latino | 9 (12.9) |
| ≥College Degree | 52 (78.1) |
| Working at Least Part-Time | 45 (67.2) |
| Annual Household Income ≥$100,000 | 31 (46.3) |
| Marital Status | |
| Married/Partnered | 45 (67.2) |
| Single | 11 (16.4) |
| Divorced/Separated | 5 (7.5) |
| Widowed | 3 (4.5) |
| Not Known | 3 (4.5) |
| Chronic Disease Diagnosis | |
| Asthma | 10 (16.9) |
| Depression | 9 (15.3) |
| Arthritis | 8 (13.6) |
| Obesity | 7 (12.1) |
| Upper Gastrointestinal Disease | 5 (8.5) |
| Osteoporosis | 4 (6.8) |
| Anxiety or Panic Disorders | 4 (6.8) |
| Visual Impairment | 4 (6.8) |
| Diabetes | 3 (5.1) |
| Degenerative Disc Disease | 3 (5.1) |
| Hearing Impairment | 2 (3.4) |
| COPD | 1 (1.7) |
| Congestive Heart Failure | 1 (1.7) |
| Overall Health Status at Baseline | |
| Excellent /Very Good | 35 (52.2) |
| Good | 25 (37.3) |
| Fair/Poor | 5 (7.5) |
| Unanswered | 2 (3.0) |
| ≥150 Minutes MVPA Pre-Cancer | 28 (44.4) |
| Disease Stage | |
| Stage I/II | 17 (80.0) |
| Stage III | 13 (20.0) |
| Chemotherapy Type | |
| Neoadjuvant | 23 (34.3) |
| Adjuvant | 44 (65.7) |
| Baseline Treatment Cycle Number | |
| Cycle 1 | 24 (35.8) |
| Cycle 2 | 43 (64.2) |